HomeProductsBioactive CompoundsImmunology & InflammationComplement SystemDanicopan
Chemical structure of CAS 1903768-17-1

Danicopan

CAS No.1903768-17-1
MDL No.MFCD32669786
MFC26H23BrFN7O3
MW580.40
InChI KeyPIBARDGJJAGJAJ-NQIIRXRSSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Danicopan is an organic molecule.

CAS No.1903768-17-1
Product NameDanicopan

Biological Targets

CFD

Associated Conditions

COVID-19·liver disease·hemolysis·paroxysmal nocturnal hemoglobinuria·atrophic macular degeneration·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Danicopan: First Approval.

Drugs • Vol. 84, Issue 5 • 2024
PMID: 38528310DOI: 10.1007/s40265-024-02023-6

Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria.

Haematologica • Vol. 106, Issue 12 • 2021
PMID: 33121236PMC: PMC8634185DOI: 10.3324/haematol.2020.261826

Discovery and Development of the Oral Complement Factor D Inhibitor Danicopan (ACH-4471).

Current medicinal chemistry • Vol. 27, Issue 25 • 2020
PMID: 31573880DOI: 10.2174/0929867326666191001130342

Chemical Approaches to Modulating Complement-Mediated Diseases.

Journal of medicinal chemistry • Vol. 61, Issue 8 • 2018
PMID: 28977749DOI: 10.1021/acs.jmedchem.7b00882

Documentation

Similar Products